hypermedica Competitors

DJO® is now Enovis -a new public company solely focused on medical technology. (NYSE: ENOV) As Enovis, we will continue our commitment to bettering lives through bringing best-in-class products and technology to market, with a concentrated focus on our customers’ needs. What sets DJO apart is a focus on the continuum of care. This includes specializations across all three phases of care: performance and mobility, surgical intervention and post-operative rehabilitation. Our products are marketed under a portfolio of brands including Aircast®, Chattanooga®, CMF™, Compex®, Companion Animal Health, DonJoy®, Dr. Comfort®, MotionMD® and ProCare®. EOE AA M/F/VET/Disability All qualified applicants will receive consideration for employment and will not be discriminated against on the basis of race, religion, color, national origin, sex, protected veteran status, disability, or any other basis protected by federal, state or local laws. The contents of this site do not constitute medical, legal or any other type of professional advice. Rather, please consult your healthcare professional for information on the courses of treatment, if any, which may be appropriate for you. Individual results may vary.

Founded in 1996, InBody has been changing the health and wellness industry for more than 30 years. InBody’s award-winning, medical-grade devices are used by professionals and consumers in the medical, fitness, research and corporate wellness verticals. Recognized for manufacturing easy, quick and precise body composition analyzers, InBody helps people redefine their health by providing accurate outputs like percent body fat, segmental muscle analysis and total body water.

Nova Biomedical is entering a new chapter. Advanced Instruments and Nova Biomedical have united to form a larger, more focused global life science tools company operating under the Nova Biomedical name. By bringing together two innovation‑driven organizations, we have expanded our capabilities across bioprocessing and clinical diagnostics, strengthening how we serve customers and accelerating our impact across life sciences. Today’s Nova Biomedical is a global leader in supporting bioprocessing workflows and in vitro diagnostics (IVD), guided by a renewed leadership team, sharper priorities, and a clear focus on innovation, quality, and customer outcomes. We are committed to advancing patient care and scientific discovery through reliable, high‑performance technologies backed by disciplined execution and long‑term investment. Our portfolio includes: Clinical Diagnostics: Blood gas, critical care, and glucose analyzers that deliver fast, accurate results to support confident clinical decisions. Bioprocessing Solutions: Cell line development solutions, real‑time cell culture monitoring and process optimization, helping customers improve productivity, quality, and scale. Veterinary Diagnostics: High‑performance diagnostic solutions designed for animal health applications. We reinvest annually into research and development, fueling a strong pipeline of breakthrough technologies and reinforcing our leadership in innovation. As the largest privately held IVD company in the U.S. and one of the fastest‑growing globally, Nova Biomedical serves customers in more than 100 countries. Our culture is grounded in integrity, accountability, and long‑term commitment, values reflected in the trust of our customers and the dedication of our people. As a new Nova Biomedical, we are focused on delivering consistent quality, meaningful innovation, and lasting impact—today and for what’s next. Learn more: www.novabiomedical.com